Synthetics-china

Country/Region: China

Main Products: Ritonavir Intermediate, Lamivudine Intermediate, Fluvastatin Intermediate, Terbinafine Intermediate, Nelfinavir Intermediate, Tenofovir Intermediate, Aliskiren Intermediate, Celecoxib Intermediate, Fluoxetine Intermediate, Mefloquine Intermediate, Ritonavir Intermediate

Company Introduction
We take pride in being a top choice among interior designers, owing to the world’s finest Tenofovir Intermediates based on quality aesthetic appeal, prevailing in the market. Our product line is specifically designed to last and level up architectures in terms of appeal, dealing in Ritonavir intermediate, Lamivudine intermediate, Fluvastatin intermediate, Terbinafine intermediate, Nelfinavir intermediate, Tenofovir intermediate, Aliskiren intermediate, Celecoxib intermediate, Fluoxetine intermediate, Mefloquine intermediate since 2012 we have captured a huge proportion of consumer base across border including Australia,Israel,Malaysia,Philippines,Singapore market share. Our professional enterprise was first introduced with Above US$100 Million under Third Party in Taizhou, Jiangsu, China. Synthetics-china LLC envisions to be listed among globally renowned Manufacturer and Retailer of Ritonavir intermediate, Lamivudine intermediate, Fluvastatin intermediate, Terbinafine intermediate, Nelfinavir intermediate, Tenofovir intermediate, Aliskiren intermediate, Celecoxib intermediate, Fluoxetine intermediate, Mefloquine intermediate. In the industry of architecture and interior the company boasts a reputable export history of 8 Years , going through which, we have successfully earned an export value estimating around US$1 Million - US$2.5 Million.
Company Overview

Business Type: Manufacturer

Business Nature: Manufacturer

Year Established: 2012, 2012

Legal Status: Third Party

Ownership: LLC

Employees: 201 - 300 People

Factory Size: 3, 000-5, 000 square meters

R&D Team Size: 5 - 10 People

Certifications: ISO17025

Contact Information

Contact Person: Yuan Sunny

Designation: Account Manager

Department: Director

Telephone: 86-15961049579

Business Information

Main Markets: Malaysia (19%) Australia (13%) Israel (12%) Philippines (12%) Singapore (10%)

Export Focus: Australia, Israel, Malaysia, Philippines, Singapore

Contract Services: OEM Service Offered

Trade & Financial Information

Annual Revenue: More than 6 Million US Dollar

Registered Capital: Above US$100 Million

Export Percentage: 41% - 50%

Payment Terms: Bank wire (T/T), MoneyGram, Credit Card (CC), PayPal

Product Showcase
Ritonavir intermediate
Lamivudine intermediate
Fluvastatin intermediate
Terbinafine intermediate
Nelfinavir intermediate
Tenofovir intermediate
Aliskiren intermediate
Celecoxib intermediate
Fluoxetine intermediate
Mefloquine intermediate
Ritonavir intermediate

CL-Link > Health & Medicines in China Health Care Supplement in China